LEILA – Hinfallen und Krone wieder richten

LEILA für Frauen und Paare, die einen unerfüllten Kinderwunsch haben Stellen Sie sich und das Startup LEILA doch kurz unseren Lesern vor! Ich bin Caroline, 30, ursprünglich Wienerin und eine der Gründerinnen von LEILA. Zusammen mit meinen Mitgründerinnen, Silvia Hecher und Dr. Theresa Vilsmaier, haben wir einen auf medizinischen Leitlinien basierenden Algorithms entwickelt, der es

LEILA – Hinfallen und Krone wieder richten2021-12-14T11:33:09+01:00

Ava Announces Launch of First Clinical Trial Evaluating Effectiveness of Its Fertility Tracking Sensor Bracelet in Real-time, Pre-Symptomatic Detection of COVID-19

Data analysis from earlier COVI-GAPP pilot study shows Ava’s algorithm accurately detected 71% of COVID-19 positive infections two days prior to symptom onset. ZURICH — March 23, 2021 — Ava, a digital healthcare company that focuses on women’s reproductive health, announced today it will be launching the first study of its kind to test whether

Ava Announces Launch of First Clinical Trial Evaluating Effectiveness of Its Fertility Tracking Sensor Bracelet in Real-time, Pre-Symptomatic Detection of COVID-192021-10-08T08:41:37+01:00

Mojo: This AI-powered microscope is really good at counting sperm

Flawed or non-existent sperm tests mean that the burden of fertility treatments too often falls on women –Mojo is looking to change that using an AI-powered microscope Mohamed Taha’s ambition to disrupt the fertility industry began after his first sperm test. He had just been diagnosed with a kidney disease (which later turned out to

Mojo: This AI-powered microscope is really good at counting sperm2021-09-30T14:23:13+01:00

AVA – Liechtenstein study aims to help combat coronavirus pandemic

Testing a promising way of detecting infection early A consortium led by Liechtenstein scientists and entrepreneurs Professor Dr. Lorenz Risch and Dr. Martin Risch has just launched a scientific study aimed at combating the coronavirus: the COVI-GAPP study. Around 2,000 individuals in Liechtenstein are taking part. The aim is to see whether a sensory bracelet,

AVA – Liechtenstein study aims to help combat coronavirus pandemic2021-12-14T14:21:54+01:00

Utility of AVA – the Ava Bracelet to Diagnose and Monitor Symptoms Potentially Related to COVID-19

The Ava Bracelet is a wrist worn medical device* that tracks breathing rate, pulse rate, skin temperature, heart rate variability and perfusion. The most common symptoms of COVID-19 include fever (87.9% of cases), dry cough (67.7% of cases), and shortness of breath (18.6% of cases).1–4 During a fever, body temperature and pulse rate increase.5–7 Shortness

Utility of AVA – the Ava Bracelet to Diagnose and Monitor Symptoms Potentially Related to COVID-192021-12-14T14:28:41+01:00

AVA – The Impact of Covid-19 on Global Healthcare

The pandemic will have profound impact on the healthcare industry. While certain developments are obvious, others are not. 1. Healthcare is getting digitalized, finally While the digital revolution has redefined most industries, the healthcare industry has resisted major change so far. Complex structures, misaligned incentive systems and a high degree of regulation have been key reasons

AVA – The Impact of Covid-19 on Global Healthcare2021-12-14T14:30:57+01:00

Digitale Schweiz Lea von Bidder zur Zukunft der digitalen Schweiz

Wer bist du und was muss ein junger Digital Native, der noch am Anfang seiner Berufskarriere steht, über dich, deine Organisation und ihre digitalen Initiativen wissen? Ava wirtschaftet seit der Gründung rein Digital. Auf das Produkt bezogen heisst das: Ava Armband mit Sensoren, Daten werden mit Hilfe unseres Algorithmus (Artifical Intelligence & Machine Learning) an

Digitale Schweiz Lea von Bidder zur Zukunft der digitalen Schweiz2021-12-14T14:23:35+01:00

Fertility startup Mojo wants to take the trial and error out of IVF

Fertility tech startup Mojo is coming out of stealth to announce a €1.7 million (~$1.8M) seed round of funding led by Nordic seed fund Inventure. Also participating are Doberman and Privilege Ventures (an investor in Ava), plus a number of angel investors including Josefin Landgard (founder and ex-CEO of Kry) and Hampus Jakobsson (venture partner

Fertility startup Mojo wants to take the trial and error out of IVF2021-09-30T15:00:25+01:00

Dank ihr gibt es 30’000 Babys

Das Aushängeschild Schweizer Jungunternehmerinnen, Lea von Bidder (29), erzählte am Montagabend im Live-Talk über ihr Startup Ava und wie sie Baby-Träume wahr macht. Doppelte Premiere am Montagabend in Zürich: Jungunternehmerin Lea von Bidder (29) nimmt nicht nur zum ersten Mal Platz auf dem Podium von «TheTalk@TheStudio». Die Veranstaltungsreihe von Ringier und der Helvetia-Gruppe zählt auch

Dank ihr gibt es 30’000 Babys2021-12-14T14:26:31+01:00

Lea von Bidder im Gespräch mit Christine Maier

Lea von Bidder (29), das Aushängeschild Schweizer Jungunternehmerinnen, erzählt im «TheTalk@TheStudio» über ihr Startup Ava und wie sie Baby-Träume wahr macht. Click  to display video https://www.blick.ch/news/wirtschaft/thetalk-thestudio-live-lea-von-bidder-im-gespraech-mit-christine-maier-id15610749.html    

Lea von Bidder im Gespräch mit Christine Maier2021-10-08T08:45:04+01:00

Ava Fertility Tracker Review

A little explanation of what the Ava Fertility Tracker is, it’s a small bracelet worn like a watch, while you sleep. Although the name of it includes fertility it has other uses such as, tracking your monthly cycle and tracking your pregnancy. Just before the weekend I finally received my Ava Fertility Tracker. I say

Ava Fertility Tracker Review2021-09-30T15:49:27+01:00

The top five wearable med-tech companies

According to new research released this week by Deloitte, the future of the healthcare industry will be closely tied to and driven by an omnipresent, proactive, and integrated system aimed at health and well-being, where technologies like AI, digital therapeutics, cloud and app-enabled digital health capabilities, augmented and virtual reality will have a leading role

The top five wearable med-tech companies2021-09-30T15:33:01+01:00

Lea von Bidder neu als CEO an der Spitze des Startups Ava

An der Spitze des Schweizer Femtech- Startups Ava, Herstellerin des ersten Fruchtbarkeits-Trackers für das Handgelenk, kommt es zu einem Führungswechsel: Lea von Bidder, Mitgründerin und aktuell VP Marketing, wird von Pascal Koenig die Rolle des CEO übernehmen. In der Führung des mehrfach ausgezeichneten Schweizer Medtech-Startups Ava kommt es zu einer Rochade. Mitgründerin Lea von Bidder

Lea von Bidder neu als CEO an der Spitze des Startups Ava2021-09-30T15:46:27+01:00

Ava expands to Asia

Ava, maker of clinically proven fertility tracking bracelet, has opened an office in Hong Kong. Ava co-founder Philipp Tholen, had moved to Hong Kong and is responsible for the expansion. In addition, the company has unveiled an improved and updated version of its fertility tracker, along with a host of new premium services available to

Ava expands to Asia2021-09-30T15:45:54+01:00

Ava – Maker of First Fertility Tracking Sensor Bracelet – Closes $30M Series B Funding Round and Announces 10,000th “Ava” Pregnancy

Funding will fuel R&D to expand product offering beyond fertility into pregnancy and contraception SAN FRANCISCO and ZURICH Ava, a medical technology company focused on innovations in women's reproductive health and maker of the popular cycle tracking Ava bracelet, today announced it has raised $30 million in a strategic Series B funding round. The majority of

Ava – Maker of First Fertility Tracking Sensor Bracelet – Closes $30M Series B Funding Round and Announces 10,000th “Ava” Pregnancy2021-09-30T15:29:48+01:00

Mojo by Nanovare

Nanovare’s team tell us about their aspirations for Data Pitch and beyond. Describe your Data Pitch challenge idea By 2020, the average man’s sperm count is expected to drop below medically acceptable levels, drastically inhibiting the ability to conceive naturally. While medical practices have taken great strides to address couples faced with fertility issues, the

Mojo by Nanovare2021-09-30T15:27:58+01:00
Go to Top